Citations

Clear

6274 citation(s) found for "To, Andrew".

A critical role for CARD9 in pneumocystis pneumonia host defence
Nandakumar, Vijayalakshmi, Hebrink, Deanne, Carmona, Eva M. , Limper, Andrew H. , Kottom, Theodore J. , Hebrink, Deanne M, Limper, Andrew H , Carmona, Eva M

Mayo Clinic

Cellular Microbiology | June 17, 2020 | Volume: 22 | Issue: 10 | Pages: No page available

10.1111/cmi.13235 | PMID 32548948 Get It

Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer
Song, Honglin , Dicks, Ed , Intermaggio, Maria P., Chenevix‐Trench, Georgia , Bowtell, David D.L. , Traficante, Nadia , Group, AOCS, Hosking, Karen, Piskorz, Anna , Oudenhove, Elke Van , Doherty, J.A. , Rossing, Mary Anne, Duerst, Matthias, Dörk, Thilo , Bogdanova, Natalia , Moysich, Kirsten B. , Odunsi, Kunle , Ness, Roberta B., Lester, Jenny, Pujara, Miguel Angel, Cunningham, Julie M. , Hildebrandt, Michelle, Huff, Chad , Li, Donghui , Wu, Xifeng , Yu, Yao , Levine, Douglas A. , Schildkraut, Joellen M. , Riggan, Marjorie J. , Webb, Penelope M. , Group, OPAL Study, Jakubowska, Anna , Alsop, Jennifer , Harrington, Patricia, Chan, Isaac H Y , Menon, Usha , Pearce, Celeste Leigh, Wu, Anna H. , Fazio, Anna de , Kennedy, Catherine J. , Goode, Ellen L. , Ramus, Susan J. , Gayther, Simon A. , DeFazio, Anna , Cunningham, Julie, Vierkant, Robert, Huff, Chad , Cybulski, Cezary , Pharoah, Paul D P , Dörk, Thilo , Ramus, Susan J , Webb, Penelope M , Menon, Usha , Moysich, Kirsten , Kennedy, Catherine J , Jakubowska, Anna , Bogdanova, Natalia V , Chenevix-Trench, Georgia , Traficante, Nadia , Bowtell, David D , Tyrer, Jonathan P. , Group, AOCS, Brenton, James D. , Goranova, Teodora , Harris, Holly R. , Modugno, Francesmary , Karlan, Beth Y. , Jensen, Allan , Kjær, Susanne K. , Høgdall, Estrid , Campbell, Ian , Lázaro, Conxi , Vierkant, Robert A. , Winham, Stacey J. , Permuth, Jennifer B. , Berchuck, Andrew , Cybulski, Cezary , Gronwald, Jacek , Lubiński, Jan , Pharoah, Paul D.P.

Mayo Clinic

Journal of Medical Genetics | June 16, 2020 | Volume: 58 | Issue: 5 | Pages: 305-313

10.1136/jmedgenet-2019-106739 | PMID 32546565 Get It

Purpose The known epithelial ovarian cancer (EOC) susceptibility genes account for less than 50% of the heritable risk of ovarian cancer suggesting that other susceptibility genes exist. The aim of this study was to evaluate the contribution to ovarian cancer susceptibility of rare deleterious germline variants in a set of candidate genes. Methods We sequenced the coding region of 54 candidate genes in 6385 invasive EOC cases and 6115 controls of broad European ancestry. Genes with an increased frequency of putative deleterious variants in cases versus controls were further examined in an independent set of 14 135 EOC cases and 28 655 controls from the Ovarian Cancer Association Consortium and the UK Biobank. For each gene, we estimated the EOC risks and evaluated associations between germline variant status and clinical characteristics. Results The ORs associated for high-grade serous ovarian cancer were 3.01 for PALB2 (95% CI 1.59 to 5.68; p=0.00068), 1.99 for POLK (95% CI 1.15 to 3.43; p=0.014) and 4.07 for SLX4 (95% CI 1.34 to 12.4; p=0.013). Deleterious mutations in FBXO10 were associated with a reduced risk of disease (OR 0.27, 95% CI 0.07 to 1.00, p=0.049). However, based on the Bayes false discovery probability, only the association for PALB2 in high-grade serous ovarian cancer is likely to represent a true positive. Conclusions We have found strong evidence that carriers of PALB2 deleterious mutations are at increased risk of high-grade serous ovarian cancer. Whether the magnitude of risk is sufficiently high to warrant the inclusion of PALB2 in cancer gene panels for ovarian cancer risk testing is unclear; much larger sample sizes will be needed to provide sufficiently precise estimates for clinical counselling.
Acute symptomatic seizures secondary to autoimmune encephalitis and autoimmune‐associated epilepsy: Conceptual definitions
Steriade, Claude , Dale, Russell C. , Gadoth, Avi , Irani, Sarosh R. , Linnoila, Jenny, Shao, Xiaoqiu , Venegas, Viviana , Bien, Christian G. , Britton, Jeffrey, Dale, Russell C , Bien, Christian G , Irani, Sarosh R , Steriade, Claude , Britton, Jeffrey W. , McKeon, Andrew

Mayo Clinic

Epilepsia | June 16, 2020 | Volume: 61 | Issue: 7 | Pages: 1341-1351

10.1111/epi.16571 | PMID 32544279 Get It

Abstract Seizures are a well‐recognized and often prominent manifestation of autoimmune encephalitic syndromes. Progress in detection of pathogenic neural autoantibodies has led to increased awareness of autoimmune causes of seizures. Clinical studies of patients with these autoantibodies have improved our understanding of the seizure characteristics, treatments, and seizure prognosis in these disorders. The International League Against Epilepsy (ILAE) Autoimmunity and Inflammation Taskforce proposes conceptual definitions for two main diagnostic entities: (a) acute symptomatic seizures secondary to autoimmune encephalitis, and (b) autoimmune‐associated epilepsy, the latter of which suggests an enduring predisposition to seizures. Such a distinction is relevant when discussing the pathophysiology, treatment, prognosis, and social consequences of these disorders. We discuss the role of biomarkers in the application of these conceptual definitions and illustrate their use in patients cared for by members of the task force.
Biomechanical evaluation of a novel double rip-stop technique with medial row knots for rotator cuff repair
Wang, Zhanwen , Long, Zeling , Lin, Subin, Thoreson, Andrew R. , Moran, Steven L. , Gingery, Anne , Amadio, Peter C. , Steinmann, Scott P. , Zhao, Chunfeng , Li, Hong , Gingery, Anne , Li, Hong

Mayo Clinic

Bone & Joint Research | June 16, 2020 | Volume: 9 | Issue: 6 | Pages: 285-292

10.1302/2046-3758.96.bjr-2019-0196.r1 | PMID 32728429 Get It

AimsMany biomechanical studies have shown that the weakest biomechanical point of a rotator cuff repair is the suture-tendon interface at the medial row. We developed a novel double rip-stop (DRS) technique to enhance the strength at the medial row for rotator cuff repair. The objective of this study was to evaluate the biomechanical properties of the DRS technique with the conventional suture-bridge (SB) technique and to evaluate the biomechanical performance of the DRS technique with medial row knots.MethodsA total of 24 fresh-frozen porcine shoulders were used. The infraspinatus tendons were sharply dissected and randomly repaired by one of three techniques: SB repair (SB group), DRS repair (DRS group), and DRS with medial row knots repair (DRSK group). Specimens were tested to failure. In addition, 3 mm gap formation was measured and ultimate failure load, stiffness, and failure modes were recorded.ResultsThe mean load to create a 3 mm gap formation in the DRSK and DRS groups was significantly higher than in the SB group. The DRSK group had the highest load to failure with a mean ultimate failure load of 395.0 N (SD 56.8) compared to the SB and DRS groups, which recorded 147.1 N (SD 34.3) and 285.9 N (SD 89.8), respectively (p < 0.001 for both). The DRS group showed a significantly higher mean failure load than the SB group (p = 0.006). Both the DRS and DRSK groups showed significantly higher mean stiffness than the SB group.ConclusionThe biomechanical properties of the DRS technique were significantly improved compared to the SB technique. The DRS technique with medial row knots showed superior biomechanical performance than the DRS technique alone.
Warfarin therapy in atrial fibrillation: assessment of patient knowledge of risks and benefits
Fitzgerald, Patrick , Kurklinsky, Andrew K., Nikpour, Naveed, McLeod, Ethan, Li, Z , Oken, Keith R. , Valery, Jose R. , Stancampiano, Fernando F , Oken, K , Stancampiano, Fernando F.

Mayo Clinic

Journal of Community Hospital Internal Medicine Perspectives | June 15, 2020 | Volume: 10 | Issue: 3 | Pages: 179-187

10.1080/20009666.2020.1767270 | PMID 32850062 Get It

Match Demands of Women’s Collegiate Soccer
Murphy, Jason, Schaefer, Alexis Q., Askow, Andrew T. , Luedke, Joel, Erickson, Jacob L. , Jones, Margaret T. , Jagim, Andrew R , Askow, Andrew T , Jones, Margaret T , Jagim, Andrew R.

Mayo Clinic

Sports | June 15, 2020 | Volume: 8 | Issue: 6 | Pages: 87

10.3390/sports8060087 | PMID 32545603 Get It

Research describing the match and specific positional demands during match play in women’s collegiate soccer is limited. The purpose of the study was to quantify the match demands of National Collegiate Athletic Association (NCAA) Division III soccer and assess position differences in movement kinematics, heart rate (HR), and energy expenditure. Twenty-five Division III women soccer players (height: 1.61 ± 0.3 m; body mass: 66.7 ± 7.5 kg; fat-free mass: 50.3 ± 6.5 kg; body fat%: 25.6 ± 5.1%) were equipped with a wearable global positioning system to assess the demands of 22 matches throughout a season. Players were categorized by position (goal keepers (GK), center defenders (CB), flank players (FP), forwards (F), and center midfielders (CM)). Players covered 9807 ± 2588 m and 1019 ± 552 m at high speeds (>249.6 m·m−1), with an overall average speed of 62.85 ± 14.7 m·m−1. This resulted in a mean HR of 74.2 ± 6% HR max and energy expenditure of 1259 ± 309 kcal. Significant and meaningful differences in movement kinematics were observed across position groups. CM covered the most distance resulting in the highest training load. FP covered the most distance at high speeds and mean HR values were highest in CM, CB, and FP positions.
A Three-Arm Randomized Phase II Study of Bendamustine/Rituximab with Bortezomib Induction or Lenalidomide Continuation in Untreated Follicular Lymphoma: ECOG-ACRIN E2408
Evens, Andrew M. , Advani, Ranjana H. , Gascoyne, Randy D. , Witzig, Thomas E. , Quon, Andrew , Ranheim, Erik A. , Ansell, Stephen M. , Cheema, P. , Dy, Philip A., O’Brien, Timothy E., Cescon, Terrence P., Chang, Julie , Witzig, T.E. , Winter, Jane N , Advani, Ranjana H , Evens, Andrew M , Hong, Fangxin , Habermann, Thomas M. , Winter, Jane N. , Kahl, Brad S.

Mayo Clinic

Clinical Cancer Research | June 12, 2020 | Volume: 26 | Issue: 17 | Pages: 4468-4477

10.1158/1078-0432.ccr-20-1345 | PMID 32532790 Get It

Abstract Purpose: We sought to improve upon frontline bendamustine/rituximab (BR) induction therapy followed by rituximab maintenance in untreated high-risk follicular lymphoma (FL). Patients and Methods: Patients were randomized to BR induction followed by 2-year rituximab maintenance (BR-R), BR with bortezomib and rituximab maintenance (BVR-R), or BR followed by lenalidomide (1 year) with rituximab maintenance (BR-LR). Dual primary objectives were complete remission (CR) rate and 1-year disease-free survival (DFS); 289 patients enrolled (NCT01216683). Results: For induction, 92%, 87%, and 86% of patients randomized to BR-R, BVR-R, or BR-LR received six cycles, respectively. CR rate with BR versus BVR induction was 62% versus 75%, respectively (P = 0.04). One-year DFS rates with BR-R versus BR-LR were 85% versus 67%, respectively (P = 0.0009). This was due to an imbalance in CR rates post-BR induction and discontinuation due to adverse events (AEs). The most common grade 3–4 AEs for BVR versus BR were neutropenia and sensory neuropathy (12% vs &lt;1%); 83% of the latter occurred with intravenous bortezomib. The most common grade 3–4 AEs related to LR versus rituximab maintenance were neutropenia 66% versus 21%, respectively (P &lt; 0.0001), and febrile neutropenia 10% versus 2%, respectively (P = 0.05). The overall treatment-related mortality was 1.4%. With 5-year median follow-up, 3-year PFS rates for BR-R, BVR-R, and BR-LR were 77%, 82%, and 76%, respectively (P = 0.36) with OS rates of 87%, 90%, and 84%, respectively (P = 0.79). For prognostication, CR rate and POD-24 were associated with survival. Conclusions: Altogether, neither bortezomib added to BR induction nor lenalidomide added to rituximab maintenance immediately post-BR induction is recommended in untreated FL.
Guidance for Rebooting Electrophysiology Through the COVID-19 Pandemic From the Heart Rhythm Society and the American Heart Association Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology
Lakkireddy, Dhanunjaya , Chung, Mina K. , Deering, Thomas F. , Gopinathannair, Rakesh , Epstein, Laurence M. , Harding, Clifford V. , Hurwitz, Jodie L. , Jeffery, Courtney, Krahn, Andrew D. , Lampert, Rachel , Mansour, Moussa , Natale, Andrea , Seiler, Amber , Shah, Maully J. , Wang, Paul J. , Russo, Andrea M. , Kusumoto, Fred M, Krahn, Andrew D , Natale, Andrea , Gopinathannair, Rakesh , Epstein, Laurence M , Albert, Christine M. , Kusumoto, Fred , Patton, Kristen K.

Mayo Clinic

Circulation: Arrhythmia and Electrophysiology | June 12, 2020 | Volume: 13 | Issue: 7 | Pages: No page available

10.1161/circep.120.008999 | PMID 32530306 Get It

Coronavirus disease 2019 (COVID-19) has presented substantial challenges to patient care and impacted healthcare delivery, including cardiac electrophysiology practice throughout the globe. Based upon the undetermined course and regional variability of the pandemic, there is uncertainty as to how and when to resume and deliver electrophysiology services for patients with arrhythmia. This joint document from representatives of the Heart Rhythm Society, American Heart Association, and American College of Cardiology seeks to provide guidance for clinicians and institutions reestablishing safe electrophysiological care. To achieve this aim, we address regional and local COVID-19 disease status, the role of viral screening and serological testing, return-to-work considerations for exposed or infected health care workers, risk stratification and management strategies based on COVID-19 disease burden, institutional preparedness for resumption of elective procedures, patient preparation and communication, prioritization of procedures, and development of outpatient and periprocedural care pathways.
Cholesterol and Monosodium Urate Monohydrate Crystals in Synovial fluid From a Patient With Gout
Bansal, Pankaj , Virata, Andrew, Virata, Andrew R, Bansal, Pankaj

Mayo Clinic

Arthritis & Rheumatology | June 11, 2020 | Volume: 72 | Issue: 10 | Pages: 1706-1706

10.1002/art.41391 | PMID 32524738 Get It